Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Phil Teale is active.

Publication


Featured researches published by Phil Teale.


Rapid Communications in Mass Spectrometry | 2008

Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis.

Richard G Kay; Chris Barton; Lucy Ratcliffe; Balwir Matharoo-Ball; Pamela Brown; Jane Roberts; Phil Teale; Colin S. Creaser

A rapid acetonitrile (ACN)-based extraction method has been developed that reproducibly depletes high abundance and high molecular weight proteins from serum prior to mass spectrometric analysis. A nanoflow liquid chromatography/tandem mass spectrometry (nano-LC/MS/MS) multiple reaction monitoring (MRM) method for 57 high to medium abundance serum proteins was used to characterise the ACN-depleted fraction after tryptic digestion. Of the 57 targeted proteins 29 were detected and albumin, the most abundant protein in serum and plasma, was identified as the 20th most abundant protein in the extract. The combination of ACN depletion and one-dimensional nano-LC/MS/MS enabled the detection of the low abundance serum protein, insulin-like growth factor-I (IGF-I), which has a serum concentration in the region of 100 ng/mL. One-dimensional sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the depleted serum showed no bands corresponding to proteins of molecular mass over 75 kDa after extraction, demonstrating the efficiency of the method for the depletion of high molecular weight proteins. Total protein analysis of the ACN extracts showed that approximately 99.6% of all protein is removed from the serum. The ACN-depletion strategy offers a viable alternative to the immunochemistry-based protein-depletion techniques commonly used for removing high abundance proteins from serum prior to MS-based proteomic analyses.


Proteomics | 2009

Multiplexed LC‐MS/MS analysis of horse plasma proteins to study doping in sport

Chris Barton; Paul Beck; Richard G Kay; Phil Teale; Jane Roberts

The development of protein biomarkers for the indirect detection of doping in horse is a potential solution to doping threats such as gene and protein doping. A method for biomarker candidate discovery in horse plasma is presented using targeted analysis of proteotypic peptides from horse proteins. These peptides were first identified in a novel list of the abundant proteins in horse plasma. To monitor these peptides, an LC‐MS/MS method using multiple reaction monitoring was developed to study the quantity of 49 proteins in horse plasma in a single run. The method was optimised and validated, and then applied to a population of race‐horses to study protein variance within a population. The method was finally applied to longitudinal time courses of horse plasma collected after administration of an anabolic steroid to demonstrate utility for hypothesis‐driven discovery of doping biomarker candidates.


Bioanalysis | 2009

Biomarkers: unrealized potential in sports doping analysis

Phil Teale; Chris Barton; Philip M Driver; Richard G Kay

The fight against doping in sport using analytical chemistry is a mature area with a history of approximately 100 years in horse racing and at least 40 years in human sport. Over that period, the techniques used and the breadth of coverage have developed significantly. These improvements in the testing methods have been matched by the increased sophistication of the methods, drugs and therapies available to the cheat and, as a result, testing has been a reactive process constantly adapting to meet new threats. Following the inception of the World Anti-Doping Agency, research into the methods and technologies available for human doping control have received coordinated funding on an international basis. The area of biomarker research has been a major beneficiary of this funding. The aim of this article is to review recent developments in the application of biomarkers to doping control and to assess the impact this could make in the future.


Drug Testing and Analysis | 2011

Analysis of methyloxime derivatives of intact esters of testosterone and boldenone in equine plasma using ultra high performance liquid chromatography tandem mass spectrometry

Bobby P. Gray; Phil Teale; Clive M. Pearce

Analysis of equine plasma samples to detect the abuse of anabolic steroids can be complicated when the parent steroid is endogenous to the animal. Anabolic steroids are usually administered intramuscularly as synthetic esters and therefore detection of the exogenous esters provides unequivocal proof of illegal administration. An ultra high performance liquid chromatography tandem mass spectrometric (UPLC-MSMS) method for the analysis of esters of testosterone (propionate, phenylpropionate, isocaproate, and decanoate) and boldenone (undecylenate) in equine plasma has been developed. Esters were extracted from equine plasma using a mixture of hexane and ethyl acetate and treated with methoxyamine hydrochloride to form methyloxime derivatives. Metenolone enanthate was used as an internal standard. After chromatographic separation, the derivatized steroid esters were quantified using selected reaction monitoring (SRM). The limit of detection for all of the steroid esters, based on a signal to noise ratio (S/N) of 3:1, was 1-3 pg/mL. The lower limit of quantification (LLOQ) for the all of the steroid esters was 5 pg/mL when 2 mL of plasma was extracted. Recovery of the steroid esters was 85-97% for all esters except for testosterone decanoate which was recovered at 62%. The intra-day coefficient of variation (CV) for the analysis of plasma quality control (QC) samples was less than 9.2% at 40 pg/mL and less than 6.0% at 400 pg/mL. The developed assay was used to successfully confirm the presence of intact testosterone esters in equine plasma samples following intramuscular injection of Durateston® (mixed testosterone esters).


Food Additives and Contaminants Part A-chemistry Analysis Control Exposure & Risk Assessment | 2011

Detection of endogenous steroid abuse in cattle: results from population studies in the UK

James P. Scarth; Adam Clarke; Phil Teale; Aileen C. Mill; Roy Macarthur; Jack Kay

The use of steroids as growth-promoting agents in food production is banned under European Union legislation. Detecting the abuse of testosterone, nandrolone, boldenone, oestradiol and progesterone is complicated by the fact that these steroids are known to be endogenous in certain situations. In this study, the concentrations of characteristic metabolites of each of these steroids were quantified in populations of untreated steers and heifers. Steroid concentration population data were then used by a statistical model (the Chebyshev inequality) to produce threshold concentrations for screening and confirming the abuse of these steroids in steer and non-pregnant heifer urine. In addition to thresholds based on testing one animal (a ‘1 out of 1’ approach), new methods based on testing multiple animals from a herd (a ‘y out of n’ approach) allowed threshold concentrations to be significantly reduced and hence false compliances to be minimised. In the majority of cases, the suggested thresholds were found to be capable of confirming the abuse of endogenous steroids in steers and heifers. In the case of oestradiol abuse in the female, however, confirmation based on a threshold is not possible and alternative methods such as gas chromatography-combustion-isotope ratio mass spectrometry are required. In addition to the steer and heifer populations, a small number of pregnant animals were also tested, yielding insights into the biosynthetic pathways of some of the steroids.


Proteomics Clinical Applications | 2009

A proteomic approach combining MS and bioinformatic analysis for the detection and identification of biomarkers of administration of exogenous human growth hormone in humans

Joshua Boateng; Richard G Kay; Lee Lancashire; Pamela Brown; Cristiana P. Velloso; Pierre Bouloux; Phil Teale; Jane Roberts; Robert C. Rees; Graham Ball; Stephen D. R. Harridge; Geoffrey Goldspink; Colin S. Creaser

An integrated MS‐based proteomic approach is described that combines MALDI‐MS and LC‐MS with artificial neural networks for the identification of protein and peptide biomarkers associated with recombinant human growth hormone (rhGH) administration. Serum from exercised males administered with rhGH or placebo was analysed using ELISA to determine insulin‐like growth factor‐I concentrations. Diluted serum from rhGH‐ and placebo‐treated subjects was analysed for protein biomarkers by MALDI‐MS, whereas LC‐MS was used to analyse tryptically digested ACN‐depleted serum extracts for peptide biomarkers. Ion intensities and m/z values were used as inputs to artificial neural networks to classify samples into rhGH‐ and placebo‐treated groups. Six protein ions (MALDI‐MS) correctly classified 96% of samples into their respective groups, with a sensitivity of 91% (20 of 22 rhGH treated) and specificity of 100% (24 of 24 controls). Six peptide ions (LC‐MS) were also identified and correctly classified 93% of samples with a sensitivity of 90% (19 of 21 rhGH treated) and a specificity of 95% (20 of 21 controls). The peptide biomarker ion with the highest significance was sequenced using LC‐MS/MS and database searching and found to be associated with leucine‐rich α‐2‐glycoprotein.


Drug Testing and Analysis | 2011

Drug metabolism in the horse: a review

James P. Scarth; Phil Teale; Tiia Kuuranne


Drug Testing and Analysis | 2011

The use of in vitro technologies and high-resolution/accurate-mass LC-MS to screen for metabolites of ‘designer’ steroids in the equine

Adam Clarke; James P. Scarth; Phil Teale; Clive M. Pearce; Lynn Hillyer


Chromatographia | 2011

UPLC-MS/MS Method for the Identification of Recombinant Human Erythropoietin Analogues in Horse Plasma and Urine

James P. Scarth; Cathrin Seibert; Pamela Brown; Phil Teale; Gavin J. Beamon; Clive M. Pearce; Richard A. Sams


The Internet Journal of Genomics and Proteomics | 2006

The Use Of Proteomic And Bioinformatics Techniques For The Detection Of Protein Biomarkers Following Growth Hormone Administration

Joshua Boateng; Lee Lancashire; Pamela Brown; Murrium Ahmad; Balwir-Matharoo Ball; Robert Davy; Shi Yu Yang; Jane Roberts; Phil Teale; Cristiana P. Velloso; Robert Rees; Graham Ball; Geoffrey Goldspink; Colin S. Creaser

Collaboration


Dive into the Phil Teale's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Graham Ball

Nottingham Trent University

View shared research outputs
Top Co-Authors

Avatar

Joshua Boateng

Nottingham Trent University

View shared research outputs
Researchain Logo
Decentralizing Knowledge